Spiriva has composed of active component Tiotropium Bromide Monohydrate, which belongs to a group of drugs known as anticholinergics. It is approved to control and prevent symptoms like wheezing, shortness of breath caused by ongoing lung disease. Boehringer Ingelheims, the fastest growing pharmaceutical company manufactures this medicine. The available is a dosage of 18 mcg.
Manufacturer: Boehringer Ingelheims
Active Ingredient: Tiotropium Bromide Monohydrate is a synthetic anticholinergic agent used as an inhalant for the treatment of acute bronchospasm due to chronic bronchitis or emphysema. It is a quaternary ammonium derivative of atropine and a long-acting muscarinic receptor antagonist that shows bronchodilating activity. This medication binds to and blocks mainly muscarinic M3 receptors located on smooth muscle cells to prevent smooth muscle contraction.
Indications: Tiotropium Bromide Monohydrate composed medicine is indicated to control and prevent symptoms like wheezing, shortness of breath caused by ongoing lung disease or chronic obstructive pulmonary disease. It also includes bronchitis and emphysema. Spiriva relaxes the muscles around the airways so that they open up and breathing becomes easy. It belongs to a class of drugs known as anticholinergics that control symptoms of breathing problems that can reduce time lost from work or school. It does not work right away and should not be used to relieve sudden breathing problems.
Action Mechanism: This mentioned medicine acts by relaxing the tiny muscles in the airways, helping to get them open and keep them open for a full 24 hours. Spiriva may take up to 4 to 8 weeks of treatment for breathing to improve.
Dosages: This medication is available in a dosage as mentioned below:
- 18 mcg: It should be taken orally with or without food as directed by the doctor
Note: Consult the doctor immediately if experience red patches on the skin, itching, rash, or swelling of the face, lips, tongue, and throat, difficulty in breathing or swallowing.